ヒラハラ ユキエ
HIRAHARA YUKIE 平原 幸恵 所属 関西医科大学 基礎看護学領域 職種 教授 |
|
論文種別 | 原著(症例報告除く) |
言語種別 | 英語 |
査読の有無 | 査読あり |
表題 | Keto form of curcumin derivatives strongly binds to Aβ oligomers but not fibrils |
掲載誌名 | 正式名:Biomaterials 略 称:Biomaterials ISSNコード:01429612 |
掲載区分 | 国外 |
巻・号・頁 | 270,pp.120686 |
著者・共著者 | Yanagisawa D, Kato T, Taguchi H, Shirai N, Hirao K, Sogabe T, Tomiyama T, Gamo K, Hirahara Y, Kitada M, Tooyama I |
発行年月 | 2021/03 |
概要 | The accumulation of β-amyloid (Aβ) aggregates in the brain occurs early in the progression of Alzheimer's disease (AD), and non-fibrillar soluble Aβ oligomers are particularly neurotoxic. During binding to Aβ fibrils, curcumin, which can exist in an equilibrium state between its keto and enol tautomers, exists predominantly in the enol form, and binding activity of the keto form to Aβ fibrils is much weaker. Here we described the strong binding activity the keto form of curcumin derivative Shiga-Y51 shows for Aβ oligomers and its scant affinity for Aβ fibrils. Furthermore, with imaging mass spectrometry we revealed the blood-brain barrier permeability of Shiga-Y51 and its accumulation in the cerebral cortex and the hippocampus, where Aβ oligomers were mainly localized, in a mouse model of AD. The keto form of curcumin derivatives like Shiga-Y51 could be promising seed compounds to develop imaging probes and therapeutic agents targeting Aβ oligomers in the brain. |
DOI | 10.1016/j.biomaterials.2021.120686 |
PMID | 33540171 |